|
extracellular structure organization
|
GO:0043062 |
148 |
0.466
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.416
|
|
|
protein hydroxylation
|
GO:0018126 |
4 |
0.222
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.161
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.153
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.149
|
|
|
antibacterial peptide secretion
|
GO:0002779 |
1 |
0.128
|
|
|
peptidyl proline hydroxylation
|
GO:0019511 |
3 |
0.113
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.103
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.094
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.093
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.091
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.086
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.084
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.081
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.080
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.080
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.079
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.079
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.077
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.075
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.073
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.071
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.070
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.069
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.068
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.067
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.067
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.066
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.065
|
|
|
antibacterial peptide production
|
GO:0002778 |
2 |
0.063
|
|
|
bone development
|
GO:0060348 |
120 |
0.060
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.060
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.058
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.058
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.058
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.055
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.054
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.053
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.053
|
|
|
ossification
|
GO:0001503 |
216 |
0.052
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.052
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.050
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.048
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.047
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.047
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.047
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.047
|
|
|
antibacterial peptide biosynthetic process
|
GO:0002780 |
2 |
0.045
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.045
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.044
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.044
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.043
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.043
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.043
|
|
|
skeletal muscle tissue regeneration
|
GO:0043403 |
20 |
0.043
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.042
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.041
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.041
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.041
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.041
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.040
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.039
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.039
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.039
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.039
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.039
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.038
|
|
|
negative regulation of catenin import into nucleus
|
GO:0035414 |
2 |
0.038
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.038
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.037
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.037
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.037
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.037
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.037
|
|
|
wound healing
|
GO:0042060 |
157 |
0.037
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.036
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.036
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.035
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.034
|
|
|
antimicrobial peptide secretion
|
GO:0002776 |
1 |
0.034
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.034
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.034
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.034
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.034
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.033
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.033
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.032
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.032
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.032
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.032
|
|
|
peptidyl proline modification
|
GO:0018208 |
6 |
0.032
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.032
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.032
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.032
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.032
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.031
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.031
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.031
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.030
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.030
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.030
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.030
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.030
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.030
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.030
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.030
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.029
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.028
|
|
|
syncytiotrophoblast cell differentiation involved in labyrinthine layer development
|
GO:0060715 |
2 |
0.028
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.028
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.028
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.028
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.027
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.027
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.027
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.027
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.026
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.026
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.026
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.026
|
|
|
gland development
|
GO:0048732 |
330 |
0.026
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.026
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.026
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.026
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.026
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.025
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.025
|
|
|
skin development
|
GO:0043588 |
220 |
0.025
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.025
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.025
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.025
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.025
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.024
|
|
|
response to superoxide
|
GO:0000303 |
16 |
0.024
|
|
|
multicellular organismal macromolecule metabolic process
|
GO:0044259 |
19 |
0.024
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.024
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.024
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.024
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.024
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.024
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.024
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
19 |
0.024
|
|
|
insulin processing
|
GO:0030070 |
2 |
0.023
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.023
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.023
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.023
|
|
|
collagen metabolic process
|
GO:0032963 |
17 |
0.023
|
|
|
negative regulation of dna replication
|
GO:0008156 |
4 |
0.023
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.023
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.023
|
|
|
glycosaminoglycan metabolic process
|
GO:0030203 |
34 |
0.023
|
|
|
regeneration
|
GO:0031099 |
38 |
0.022
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.022
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.022
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.022
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.022
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.022
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.022
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.022
|
Mouse |
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.022
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.021
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.021
|
|
|
ear development
|
GO:0043583 |
200 |
0.021
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.021
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.021
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.021
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.021
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.021
|
|
|
regulation of response to oxidative stress
|
GO:1902882 |
19 |
0.021
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
22 |
0.021
|
|
|
protein processing
|
GO:0016485 |
163 |
0.021
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.020
|
|
|
early endosome to late endosome transport
|
GO:0045022 |
2 |
0.020
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.020
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.020
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.020
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.020
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.020
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.020
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.020
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.020
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.020
|
|
|
cerebellum vasculature morphogenesis
|
GO:0061301 |
1 |
0.020
|
|
|
multicellular organismal catabolic process
|
GO:0044243 |
7 |
0.020
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.020
|
|
|
collagen biosynthetic process
|
GO:0032964 |
7 |
0.020
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.020
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.019
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.019
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.019
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.019
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.019
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.019
|
|
|
cell growth
|
GO:0016049 |
130 |
0.019
|
|
|
mucopolysaccharide metabolic process
|
GO:1903510 |
25 |
0.019
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.019
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.019
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.019
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.019
|
|
|
tissue regeneration
|
GO:0042246 |
22 |
0.019
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.019
|
|
|
negative regulation of mitotic cell cycle embryonic
|
GO:0045976 |
2 |
0.018
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.018
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.018
|
|
|
regulation of hepatocyte differentiation
|
GO:0070366 |
2 |
0.018
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.018
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.018
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.018
|
|
|
positive regulation of nucleocytoplasmic transport
|
GO:0046824 |
30 |
0.018
|
|
|
regulation of chorionic trophoblast cell proliferation
|
GO:1901382 |
1 |
0.018
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.018
|
|
|
basement membrane organization
|
GO:0071711 |
8 |
0.018
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.018
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.018
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.018
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.018
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.018
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.018
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.018
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.018
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.018
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.017
|
|
|
cerebellum vasculature development
|
GO:0061300 |
1 |
0.017
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.017
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.017
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.017
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.017
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.017
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.017
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.017
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.017
|
|
|
negative regulation of macrophage chemotaxis
|
GO:0010760 |
1 |
0.017
|
|
|
establishment of glial blood brain barrier
|
GO:0060857 |
2 |
0.017
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.016
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.016
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.016
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.016
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.016
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.016
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.016
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.016
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.016
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.016
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.016
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.016
|
|
|
maintenance of protein location in nucleus
|
GO:0051457 |
2 |
0.016
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.016
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.016
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.016
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.016
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.016
|
|
|
renal system development
|
GO:0072001 |
225 |
0.016
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.016
|
|
|
regulation of bone mineralization
|
GO:0030500 |
31 |
0.016
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.015
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.015
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.015
|
|
|
tube formation
|
GO:0035148 |
140 |
0.015
|
|
|
positive regulation of blood pressure
|
GO:0045777 |
21 |
0.015
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.015
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.015
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.015
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.015
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.015
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.015
|
|
|
peripheral nervous system axon regeneration
|
GO:0014012 |
2 |
0.015
|
|
|
progesterone secretion
|
GO:0042701 |
1 |
0.015
|
|
|
citrulline metabolic process
|
GO:0000052 |
3 |
0.015
|
|
|
microtubule cytoskeleton organization involved in mitosis
|
GO:1902850 |
4 |
0.015
|
|
|
lung development
|
GO:0030324 |
164 |
0.015
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.015
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.015
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.015
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.014
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.014
|
|
|
positive regulation of glucose transport
|
GO:0010828 |
16 |
0.014
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.014
|
|
|
negative regulation of hepatocyte differentiation
|
GO:0070367 |
1 |
0.014
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.014
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.014
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.014
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.014
|
Worm |
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.014
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.014
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.014
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.014
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.014
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.014
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.014
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.014
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.014
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.014
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.014
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.014
|
|
|
chorionic trophoblast cell proliferation
|
GO:0097360 |
1 |
0.014
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.014
|
|
|
amide transport
|
GO:0042886 |
138 |
0.014
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.013
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.013
|
|
|
regulation of cytokine production involved in immune response
|
GO:0002718 |
26 |
0.013
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.013
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.013
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.013
|
|
|
dna replication
|
GO:0006260 |
52 |
0.013
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.013
|
|
|
response to vitamin d
|
GO:0033280 |
3 |
0.013
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.013
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.013
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.013
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.013
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.013
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.013
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.013
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.013
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.013
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.013
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.013
|
|
|
heparin metabolic process
|
GO:0030202 |
3 |
0.013
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.013
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.012
|
|
|
glucose import
|
GO:0046323 |
32 |
0.012
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.012
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.012
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.012
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.012
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.012
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.012
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.012
|
|
|
aminoglycan metabolic process
|
GO:0006022 |
34 |
0.012
|
|
|
inter male aggressive behavior
|
GO:0002121 |
3 |
0.012
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.012
|
|
|
non canonical wnt signaling pathway
|
GO:0035567 |
33 |
0.012
|
|
|
multicellular organismal metabolic process
|
GO:0044236 |
28 |
0.012
|
|
|
response to drug
|
GO:0042493 |
75 |
0.012
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.012
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.012
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.012
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.012
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.012
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.012
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.012
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.012
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.012
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.012
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.012
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.012
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.012
|
|
|
cell death in response to oxidative stress
|
GO:0036473 |
24 |
0.011
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.011
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.011
|
|
|
cell killing
|
GO:0001906 |
67 |
0.011
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.011
|
|
|
regulation of smad protein import into nucleus
|
GO:0060390 |
3 |
0.011
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.011
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.011
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.011
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.011
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.011
|
|
|
positive regulation of smad protein import into nucleus
|
GO:0060391 |
2 |
0.011
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.011
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.011
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.011
|
|
|
cellular response to superoxide
|
GO:0071451 |
14 |
0.011
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.011
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.011
|
|
|
regulation of leukocyte mediated cytotoxicity
|
GO:0001910 |
38 |
0.011
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.011
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.011
|
|
|
fucosylation
|
GO:0036065 |
9 |
0.011
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.011
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.011
|
|
|
anion transport
|
GO:0006820 |
177 |
0.011
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.011
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.011
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.011
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.011
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.011
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.011
|
|
|
negative regulation of biomineral tissue development
|
GO:0070168 |
11 |
0.011
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.011
|
|
|
embryonic nail plate morphogenesis
|
GO:0035880 |
3 |
0.011
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.011
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.011
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.011
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.010
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.010
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.010
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.010
|
|
|
negative regulation of execution phase of apoptosis
|
GO:1900118 |
4 |
0.010
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.010
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
27 |
0.010
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.010
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.010
|
|
|
positive regulation of protein import into nucleus
|
GO:0042307 |
26 |
0.010
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.010
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.010
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.010
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.010
|
|
|
response to alkaloid
|
GO:0043279 |
34 |
0.010
|
|